Value202020212022202320242025TTMCash from investing activities-4.41 M-5.37 M-2.95 M5.89 M01.17 M1.17 MCash from financing activities78.12 M70.85 M34.06 M-26.08 M11.27 M14.53 M14.53 MFree cash flow-41.73 M-59.03 M-68.14 M-49.59 M-11.41 M-5.26 M-5.26 M
Mustang Bio Inc
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency.